Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2022-12-20 2022-12-20
Drug Identification Number 00585092 00585092
Brand name DEPO-PROVERA DEPO-PROVERA
Common or Proper name MEDROXYPROGESTERONE ACETATE SUSPENSION MEDROXYPROGESTERONE ACETATE SUSPENSION
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE
Strength(s) 150MG 150MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 1mL 1 x 1mL
ATC code G03AC G03AC
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-08-05 2022-08-05
Remaining supply date 2022-08-05 2022-08-05
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments As indicated on posting 131486, product in status CANCELLED POST MARKET. No more supply in Vial format for Depo-Provera. Other presentation available, pre-filled syringes (DIN 02523493). As indicated on posting 131486, product in status CANCELLED POST MARKET. No more supply in Vial format for Depo-Provera. Other presentation available, pre-filled syringes (DIN 02523493).
Health Canada comments